Primary repair during the neonatal period for tetralogy of Fallot (RIFAN): a multicentre randomised controlled trial protocol in China

STRENGTHS AND LIMITATIONS OF THIS STUDY

  • The multicentre randomised design compares planned neonatal and infant repair among clinically stable term neonates with isolated tetralogy of Fallot.

  • Standardised perioperative and longitudinal assessments will describe outcomes beyond the index admission.

  • The results will not directly apply to infants who require urgent neonatal intervention, are preterm or have low birth weight.

  • Surgeons and caregivers cannot be blinded to operative timing, although outcome assessment and analysis will be masked where feasible.

  • The co-primary outcomes are anchored to surgery; waiting-period events require separate reporting, and low event rates may limit precision.

  • Introduction

    Child health is a fundamental component of population health, and the neonatal mortality rate is widely recognised as a key indicator of overall health status and socioeconomic development. Congenital heart disease (CHD), the most common birth defect in newborns, remains a major cause…
    This post was originally published on https://bmjopen.bmj.com